Showing results (71-80 of 124) with videos related to
Sort By:
Pageof 13
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.American Heart Journal|September 11, 2013
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDavid A Garcia, Lars Wallentin, Renato D Lopes, et al.Nature Communications|December 2, 2017
Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approachesVirginie Mariot, Romain Joubert, Christophe Hourdé, et al.Circulation|June 7, 2018
Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial FibrillationAbhinav Sharma, Ziad Hijazi, Ulrika Andersson, et al.Journal of the American College of Cardiology|April 9, 2013
N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation)Ziad Hijazi, Lars Wallentin, Agneta Siegbahn, et al.The Lancet. Neurology|May 20, 2023
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trialShengyuan Yu, Byung-Kun Kim, Aihong Guo, et al.The Lancet. Neurology|May 11, 2012
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trialJ Donald Easton, Renato D Lopes, M Cecilia Bahit, et al.International Journal of Cardiology|November 7, 2013
Apixaban in patients with atrial fibrillation and prior coronary artery disease: insights from the ARISTOTLE trialMaria Cecilia Bahit, Renato D Lopes, Daniel M Wojdyla, et al.Frontiers in Neurology|September 15, 2023
The mutational profile in a South African cohort with inherited neuropathies and spastic paraplegiaAmokelani C Mahungu, Elizabeth Steyn, Niki Floudiotis, et al.European Heart Journal|February 25, 2014
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trialSigrun Halvorsen, Dan Atar, Hongqiu Yang, et al.Pageof 13